NCT01548157View on ClinicalTrials.gov

Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

HCP1007 / omarco and crestor

HCP1007 / Rosuvastatin plus Omega-3

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY